- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 260.97M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 262.61M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 262.67M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 261.42M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $990.95M |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $1.44B |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $134.31M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $387.16M |
| Capex | Q3 2026 · Mar 31, 2026 | $6.21M |
| Capex | Q3 2026 · Mar 31, 2026 | $29.61M |
| Capex | Q3 2026 · Mar 31, 2025 | $14.37M |
| Capex | Q3 2026 · Mar 31, 2025 | $29.85M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $567.48M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $873.99M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $652.68M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $1.09B |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $989.08M |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $987.68M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $1.14B |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $2.51B |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $2.66B |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $879.03M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $1.59B |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $1.35B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $1.37B |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $1.22B |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $1.03B |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $3.32B |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $3.18B |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $4.77B |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $4.7B |
| Current Assets | Q3 2026 · Mar 31, 2026 | $2.33B |
| Current Assets | Q3 2026 · Jun 30, 2025 | $3.89B |
| Total Assets | Q3 2026 · Mar 31, 2026 | $5.65B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $6.04B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.38 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.73 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.27 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.89 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.38 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.73 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.27 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.89 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $214.51M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $586.5M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $168.35M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $483.69M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $926.95M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $2.51B |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $685.32M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $1.97B |
| Net Income | Q3 2026 · Mar 31, 2026 | −$98.39M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$192.9M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$70.81M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$232.78M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$56.28M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$200.37M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$12.46M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$101.91M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $1.52B |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $4.05B |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $1.14B |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $3.17B |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.79B |
| Revenue | Q3 2026 · Mar 31, 2026 | $4.81B |
| Revenue | Q3 2026 · Mar 31, 2025 | $1.36B |
| Revenue | Q3 2026 · Mar 31, 2025 | $3.83B |